Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 14 clinical trials
The Pharmacokinetics Safety and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age

The purpose of this study is to examine the pharmacokinetics, safety, and tolerability of abacavir/dolutegravir/lamivudine dispersible and immediate release tablets in HIV-1-infected children

atazanavir
hiv viral load
HIV Vaccine
hiv dna
antiretroviral therapy
  • 30 views
  • 14 Feb, 2021
  • 14 locations
A Study to Evaluate the Pharmacokinetics Safety Tolerability and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years

investigator-selected background regimen containing 2 nucleoside/nucleotide reverse transcriptase inhibitors (N[t]RTIs) (zidovudine [AZT], abacavir [ABC], or tenofovir disoproxil fumarate [TDF] in combination

  • 169 views
  • 28 Jan, 2021
  • 25 locations
A Dose-Range Finding Clinical Trial Study in Human Immunodeficiency Virus (HIV-1) Infected Treatment-Naive Adults

the safety, efficacy and dose-response of GSK3640254 compared to dolutegravir (DTG), each given in combination with 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) (abacavir/lamivudine [ABC/3TC

  • 0 views
  • 13 Apr, 2021
  • 44 locations
Dolutegravir Study in HIV-1 Participants Completing IMPAACT Studies P1093 and P2019

Dolutegravir is a potent integrase strand transfer inhibitor. Abacavir/dolutegravir/lamivudine (ABC/DTG/3TC) is a fixed dose combination regimen containing two nucleoside reverse transcriptase

immunodeficiency
abacavir
antiviral drugs
hiv-1 rna measurement
HIV Vaccine
  • 188 views
  • 27 Jan, 2021
  • 15 locations
SHARE: Simple HAART With Abacavir Reyataz and Epivir

SHARE: Simple HAART with Abacavir, Reyataz, and Epivir

epzicom
ritonavir
antiretroviral agents
abacavir
abacavir/lamivudine
  • 8 views
  • 07 Nov, 2020
  • 1 location
Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients

The study will investigate whether combination antiretroviral therapy of raltegravir and 3TC/ABC is effective and safe to use in tuberculosis (TB)/HIV co-infected adults receiving rifabutin-containing, first-line antituberculous treatment. Hypothesis:Combination antiretroviral therapy of raltegravir and 3TC/ABC and is effective and safe to use in tuberculosis (TB)/HIV co-infected adults receiving rifabutin-based first-line …

antiretroviral agents
abacavir
abacavir/lamivudine
mycobacterium tuberculosis
hiv-1 rna measurement
  • 6 views
  • 08 Nov, 2020
  • 1 location
Effects of Biktarvy on CFR in Stable HIV Patients

tolerated, with few discontinuations for adverse events. As a result, B/F/TAF is an ideal non-abacavir containing regimen to assess the effect of removing ABC on coronary flow reserve.

hypertension
abacavir
abacavir/lamivudine
emtricitabine
HIV Vaccine
  • 0 views
  • 28 Jan, 2021
  • 2 locations
HIV-1 Infected Patients Phase II Trial Dual Combination Doravirine/Raltegravir Open Label

The objective of antiretroviral therapy (ART) is the maintenance of HIV viral suppression, the optimal condition to prevent disease progression, to optimize immune restoration, to prevent the development of viral resistance and to reduce viral transmission. Antiretroviral therapy has to be maintained long life over decades in the absence of …

  • 0 views
  • 12 Feb, 2021
  • 1 location
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.

The purpose of the Antiretroviral Pregnancy Registry (Registry) is to detect any major teratogenic effect involving any of the Registry drugs when administered to pregnant women. Registration is voluntary and confidential with information obtained from the health care provider. A Registry-assigned identifier allows for follow-up capability. Information on subjects is …

HIV Vaccine
antiretroviral agents
antiretroviral
antiretrovirals
hepatitis
  • 66 views
  • 25 Jan, 2021
  • 1 location
Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

Due to the potential for pregnancy-induced changes in the pharmacokinetics of medication, one cannot assume that the currently licensed doses of the medication to be tested under this protocol lead to adequate exposure in an HIV-infected pregnant woman. For the agents under study no or limited pharmacokinetic data during pregnancy …

hiv antibody
immune globulin
antiretroviral agents
hiv antibodies
antibody test
  • 156 views
  • 25 Mar, 2021
  • 25 locations